跳至主要内容
临床试验/NCT05231161
NCT05231161已完成不适用

Diagnostic Performance of Exercise Stress Tests for the Detection of Epicardial and Microvascular Coronary Artery Disease

Onze Lieve Vrouw Hospital1 个研究点 分布在 1 个国家目标入组 114 人开始时间: 2019年12月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
114
试验地点
1
主要终点
The primary objective was to determine the false discovery rate of exercise stress tests using an interventional diagnostic procedure (IDP) with indexes of epicardial (FFR) and microvascular resistance (IMR) as clinical references.

研究概览

简要总结

Prospective, single-arm, multicenter study of patients with an intermediate pre-test probability of CAD and positive exercise stress tests referred for invasive angiography. Patients underwent an invasive diagnostic procedure (IDP) with measurement of fractional flow reserve (FFR) and index of microvascular resistance (IMR) in at least one coronary vessel. The objective was to determine the false discovery rate (FDR) of cardiac exercise stress tests with both FFR and IMR as references.

详细描述

The Redefining the Diagnostic Performance of Non-invasive Tests for the Detection of Coronary Artery Disease: UZ Clear is an investigator-initiated, single-arm, multicenter, prospective study of patients presenting with chest pain with an intermediate probability of CAD. The intermediate pre-test probability of CAD was defined based on the European Society of Cardiology Guidelines as a score between 15% and 85% based on age, sex, and the nature of symptoms. All patients had a positive exercise stress test and were referred for an invasive evaluation. Patients underwent a study protocol with an invasive diagnostic procedure (IDP) consisting of measurements of FFR and IMR in at least one coronary vessel. Exclusion criteria are acute coronary syndromes, known coronary artery disease, previous myocardial infarction, previous revascularization, and abnormal baseline electrocardiogram (ECG). All data were centrally collected and analyzed by the core laboratory.

The primary objective was to determine the false discovery rate of exercise stress tests using an interventional diagnostic procedure (IDP) with indexes of epicardial (FFR) and microvascular resistance (IMR) as clinical references. The secondary objective was to assess the impact of an IDP accounting for the presence of CMD on the accuracy of exercise stress tests.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Stable angina-like chest pain (typical or atypical) with intermediate (15-85%) pre-test probability of coronary artery disease using the ESC criteria.
  • Positive non-invasive exercise test, or inconclusive stress with additional positive imaging.

排除标准

  • Age <30 or >80-year old
  • Acute coronary syndromes.
  • Known coronary artery disease
  • Inability to perform exercise tests.
  • Previous myocardial infarction.
  • Previous CABG/PCI
  • Left ventricular dysfunction EF <35% or NYHA class III-IV
  • Uncontrolled or recurrent ventricular tachycardia
  • Atrial fibrillation
  • Severe renal dysfunction, defined as an eGFR <30 ml/min/1.73m2
  • Contra-indication to adenosine (e.g. asthma bronchial, severe COPD)
  • Active cancer
  • Recent stroke
  • Cardiomyopathy (dilated, hypertrophic, amyloidosis, arrhythmogenic right ventricular dysplasia)
  • Left Bundle Branch Block or baseline ST-segment depression >1mm.
  • Congenital heart disease
  • More than moderate valve disease

结局指标

主要结局

The primary objective was to determine the false discovery rate of exercise stress tests using an interventional diagnostic procedure (IDP) with indexes of epicardial (FFR) and microvascular resistance (IMR) as clinical references.

时间窗: Immediately post-procedural

Diagnostic performance of exercise tests with false discovery rate

次要结局

  • to assess the impact of an IDP accounting for the presence of CMD on the accuracy of exercise stress tests.(Immediately post-procedural)

研究者

发起方
Onze Lieve Vrouw Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Carlos Collet

Co-director Cardiovascular Center OLV Aalst

Onze Lieve Vrouw Hospital

研究点 (1)

Loading locations...

相似试验